INTRODUCTION AND OBJECTIVES:
In this video we demonstrate the feasibility of Holmium laser enucleation of the prostate (HoLEP) for retreatment of persistent lower urinary tract symptoms (LUTS) after previous treatment with the UroLift device. Technical considerations with regards to both enucleation and morcellation of resected tissue are discussed. Benign prostatic hyperplasia (BPH) affects millions of men worldwide. The UroLift system (NeoTract Inc., Pleasanton, CA) was recently introduced as a means to perform prostatic urethral lift (PUL) procedure for lateral lobe hypertrophy in patients with obstructive voiding symptoms. Urolift has been associated with a retreatment rate of 7% at 2 years and 14% at 4 years. Retreatment with TURP, photovaporization of the prostate and repeat UroLift has been described without notable issue, but retreatment with HoLEP has not yet been described. METHODS: We included two patients who had undergone PUL with UroLift system at outside institutions and presented with recurrent LUTS. Patients were evaluated by cystoscopy, uroflowmetry, transrectal ultrasound of the prostate, and urodynamics to define the etiology of their urinary symptoms and determine appropriate therapy. HoLEP was performed under general anesthesia as previously described. Morcellation of the resected adenoma was performed with the VersaCut reciprocating morcellator (Lumenis Inc, Santa Clara, CA).
RESULTS: Enucleation was successfully completed in both patients. Monofilament sutures of the Urolift device were easily visualized and transected with the holmium laser. At the bladder neck, both patients were unexpectedly found to have the outer nitinol tab portions of UroLift devices located within the capsule of the prostate, rather than in the intended extracapsular location. Auxiliary maneuvers were required for removal of these nitinol tabs. The inner stainless steel portions of the UroLift device were encountered during morcellation of the resected adenoma. In each instance, the metal tabs became lodged in the reciprocating blades of the morcellator, requiring withdrawal of the morcellator instrument and manual removal of the tab from the morcellator blade. This resulted in brief disruptions in the procedure. There were no operative complications.
CONCLUSIONS: To our knowledge, we present the first description of HoLEP with morcellation of adenoma tissue after previous prostatic urethral lift surgery with the UroLift device. HoLEP can be performed safely and effectively post Urolift, however morcellation of the adenoma tissue is complicated by the metallic implants of the Urolift device. However, the last EAU guidelines advise to perform an UC prior to minimally invasive/surgical therapies if the findings may change treatment. We assessed the feasibility of voiding urethrocystoscopy (VUC) in males with (LUTS) and describe the characteristics of dynamic movements of the prostatic lobes during micturition, with further implications for surgical approach such as preservation ejaculatory function.
METHODS: All consecutive patients with LUTS and willing to preserve their ejaculatory function scheduled for BPO relief surgery in a tertiary reference center were included in this prospective evaluation. After emptying the bladder, an UC with a 16-Fr flexible endoscope was performed and the bladder was filled up to 500mL to generate a desire to void. The patient was asked to void once the tip of the endoscope facing the veru montanum. Movements of the prostatic lobes during micturition were characterized. Endoscopic movements of the prostatic lobes were video-recorded, and categorized based on the dynamics of the lateral lobes, the posterior lobe and the bladder neck.
RESULTS: 192 procedures were conducted. In 161 cases (84%), the patient was able to void. Among these patients, 126 cases were stated as "closed" (coalescent), without opening of the initial part of the urethra and the bladder neck. In 38 cases, there was no opening of the lateral lobes (type 1A), and in 47 cases a partial opening of the distal parts of the lateral lobes was seen (type 1B). In 31 cases, a fixed posterior bladder neck was seen (type 2A) and in 10 cases a mobile median lobe, with a rolling ball effect, was seen (type 2B). In 25 cases, the lumen was completely open and equivocal in 10 cases.
CONCLUSIONS: This study demonstrates the feasibility of VUC and describes for the first time the dynamics of prostatic lobes during micturition. This functional description may be useful to evaluate preoperatively the possibility of partial surgery, meaning removal of the only visually obstructive responsible structure to restore correct urinary flow, and subsequently preservation of ejaculatory function. In this study, 70% of patients could benefit of such surgery since the obstruction was partial (types 1B, 2A and 2B).
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V5-03 ROBOT-ASSISTED PERIPROSTATIC ARTIFICIAL URINARY SPHINCTER IMPLANTATION IN MALE PATIENT WITH NEUROGENIC STRESS URINARY INCONTINENCE
benoit peyronnet*, s ebastien vincendeau, pierre grison, quentin alimi, lucas freton, lauranne tondut, baptiste gires, karim bensalah, nelly senal, jacques kerdraon, andrea manunta, rennes, France INTRODUCTION AND OBJECTIVES: In men with urinary incontinence due to neurogenic intrinsic sphincter insufficiency, it is recommended to place artificial urinary sphincter (AUS) cuff around the bladder neck to spare antegrade ejaculation, to avoid the risk of pressure ulcers at the perineal incision site and to limit the risk of cuff erosion due to clean-intermittent-self-catheterization (CISC). The objective of this study was to describe a surgical technique of periprostatic AUS implantation in neurogenic male patients.
METHODS: The technique of periprostatic AUS implantation in men is described in this video. We present the case of a 50 year-old male with a past medical history of cauda equina syndrome and stress urinary incontinence due to neurogenic intrinsic sphincter deficiency. The patient performed 5 to 6 CISC per day due to underactive bladder. The urethral closure pressure was 33 cm H2O on urodynamics and the amount of urine leakage was 350 g/24 hour according to the pad test.
RESULTS: The procedure is performed under general anesthesia. The patient is placed in a 23
Trendelenburg position. A laparoscopic transperitoneal approach is performed and five ports are placed in total, including three ports for the robotic arms and one 12 Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e599
